Skip to main content

Clinical

RSS  

Articles

  • Preventing Preterm Birth in Twins

    A recent review of the literature evaluating methods to decrease preterm birth in twins has shown little or no benefit of bed rest, cerclage, or 17 alpha-hydroxy progesterone.
  • Clinical Briefs in Primary Care

    Extended Treatment of VTE with Dabigatran vs Warfarin; Selection Criteria for Lung Cancer Screening; Special Subgroups in Hypertension: Obese Hypertensives; Omalizumab for Asthma in Real Life; Tenofovir: New Hope for Hepatitis B Patients; H. pylori: Frequency of Recurrence After Successful Eradication
  • Put US SPR guidance into your practice

    A new American College of Obstetricians and Gynecologists committee opinion has endorsed use of the U.S. Selected Practice Recommendations for Contraceptive Use, 2013 (US SPR) in counseling patients about how to most effectively use current birth control methods.
  • Lawmakers step in to protect confidentiality

    One problem that policymakers are confronting as they implement the Affordable Care Act (ACA) is that even if people gain health insurance coverage, they might not always be willing to use it.
  • Classify the causes of abnormal uterine bleeding

    In a national study, menstrual disorders accounted for 19.1% of 20.1 million physician office visits for gynecologic conditions over two years.
  • LARC methods: 7 things you need to know

    More women are now choosing long-acting reversible contraceptive (LARC) methods, such as intrauterine devices (IUDs) and the subdermal contraceptive implant. The number of women using LARC methods rose from 2.4% in 2002 to 8.5% in 2009.
  • How to get into heads of teens in initial visit

    Make the first reproductive health visit for a young teen a successful one by using the HEEADSSS (Home environment, Education and employment, Eating, peer-related Activities, Drugs, Sexuality, Suicide/depression, and Safety from injury and violence) method of interviewing in performing a psychosocial review of systems.
  • Potential HPV vaccine shows promise.

    Just-released results from international trials indicate a potential vaccine, designed to protect against nine HPV strains, might be the next step in cervical cancer protection. In the pivotal Phase III efficacy study, the investigational 9-valent HPV vaccine prevented approximately 97% of cervical, vaginal, and vulvar pre-cancers caused by HPV types 31, 33, 45, 52, and 58.
  • Clinical Briefs in Primary Care

    Continuing Warfarin for Pacemaker/ICD Implantation is Safer Than Bridging; Bariatric Surgery Impact on Cholesterol Metabolism; The Do-it-Yourself Diabetes Diagnosis Kit; Low Creatinine Excretion Associated with Mortality in Type 2 Diabetes; Diabetes and Cognitive Function; Benefits of Screening for Lung Cancer with Low-Dose CT
  • STI: CDC launches STD treatment mobile app